These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39339909)

  • 1. MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus.
    DeBarros K; Khan M; Coleman M; Bond VC; Floyd V; Gbodossou E; Diop A; Krumpe LRH; O'Keefe BR; Powell MD
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
    Chen Y; Wu Y; Chen S; Zhan Q; Wu D; Yang C; He X; Qiu M; Zhang N; Li Z; Guo Y; Wen M; Lu L; Ma C; Guo J; Xu W; Li X; Li L; Jiang S; Pan X; Liu S; Tan S
    J Virol; 2022 Dec; 96(24):e0124522. PubMed ID: 36468859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein.
    Shuster A; Pechalrieu D; Jackson CB; Abegg D; Choe H; Adibekian A
    ACS Chem Biol; 2021 Dec; 16(12):2845-2851. PubMed ID: 34792325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.
    Yang LJ; Chen RH; Hamdoun S; Coghi P; Ng JPL; Zhang DW; Guo X; Xia C; Law BYK; Wong VKW
    Phytomedicine; 2021 Jul; 87():153591. PubMed ID: 34029937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.
    Zhan Y; Ta W; Tang W; Hua R; Wang J; Wang C; Lu W
    Drug Dev Res; 2021 Dec; 82(8):1124-1130. PubMed ID: 33847382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.
    Freidel MR; Armen RS
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of Omicron (B1.1.529) pseudovirus.
    Cao X; Huang L; Tang M; Liang Y; Liu X; Hou H; Liang S
    Virulence; 2024 Dec; 15(1):2339703. PubMed ID: 38576396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
    Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
    J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Spike Inhibitors against SARS-CoV-2 Infection.
    Tai LT; Yeh CY; Chang YJ; Liu JF; Hsu KC; Cheng JC; Lu CH
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y
    J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 spike fusion peptide
    Singh P; Pahari P; Mukherjee S; Karmakar S; Hoffmann M; Mandal T; Das DK
    mBio; 2024 Sep; 15(9):e0107724. PubMed ID: 39115315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.
    Tang X; Liu Y; Wang J; Long T; Yee Mok BW; Huang Y; Peng Z; Jia Q; Liu C; So PK; Pui-Kam Tse S; Hei Ng C; Liu S; Sun F; Tang S; Yao ZP; Chen H; Guo Y
    J Biol Chem; 2024 Jun; 300(6):107390. PubMed ID: 38777146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6.
    Das T; Luo S; Tang H; Fang J; Mao Y; Yen HH; Dash S; Shajahan A; Pepi L; Huang S; Jones VS; Xie S; Huang GF; Lu J; Anderson B; Zhang B; Azadi P; Huang RP
    Microbiol Immunol; 2024 May; 68(5):165-178. PubMed ID: 38444370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia.
    Singh SK; Singh S; Singh R
    J Ovarian Res; 2021 Sep; 14(1):126. PubMed ID: 34579761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.